Impact of OncoDoc2 on Guideline Compliance in the Management of Breast Cancer
NCT00728442 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 816
Last updated 2013-09-04
Summary
The objective of the study is to evaluate how the use of OncoDoc2, a computerized guideline-based decision support system, could improve the compliance of multidisciplinary staff meeting decisions with local clinical practice guidelines in the management of non-metastatic breast cancer.
Conditions
Interventions
- DEVICE
-
ONCODOC LOGICIEL
Introduction of a computer-based decision support system in the medical decision process
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Serge UZAN, MD, PhD · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2010-04-30
- Completion
- 2011-04-30
Countries
- France
Study Locations
More Related Trials
-
Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer
NCT01254526 ·Status: COMPLETED ·Phase: PHASE1
-
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
NCT00425672 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer
NCT07021846 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Chemotherapy in Breast Cancer
NCT04802941 ·Status: UNKNOWN ·Phase: NA
-
A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
NCT02684032 ·Status: COMPLETED ·Phase: PHASE1
-
GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer
NCT00617968 ·Status: COMPLETED ·Phase: PHASE2
-
Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry Study
NCT02393924 ·Status: COMPLETED
-
A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast Cancer
NCT01740336 ·Status: COMPLETED ·Phase: PHASE2
-
Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer
NCT01190345 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer
NCT01263613 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
NCT06800612 ·Status: RECRUITING
-
Docetaxel or Paclitaxel in Treating Women With Unresectable Locally Advanced or Metastatic Breast Cancer
NCT00006120 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination Deficiency
NCT02789332 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer
NCT01440413 ·Status: UNKNOWN ·Phase: NA
-
Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancers
NCT01367288 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
NCT00270894 ·Status: COMPLETED ·Phase: PHASE2
-
Oncotype DX DCIS: Impact on Radiotherapy Decision Making
NCT06046664 ·Status: UNKNOWN ·Phase: NA
-
A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer
NCT00378313 ·Status: COMPLETED ·Phase: PHASE2
-
Biweekly Docetaxel in Patients With Metastatic Breast Cancer.
NCT02041351 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on Neoadjuvant Therapy for Her-2 Positive Breast Cancer and the Prognosis by Detecting CTCs
NCT02510781 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
NCT03301350 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Plasma Alcohol Concentration in Patients Receiving Paclitaxel or Docetaxel
NCT01448759 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
NCT05159193 ·Status: RECRUITING ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer
NCT02846428 ·Status: COMPLETED ·Phase: PHASE2
-
Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
NCT05134922 ·Status: AVAILABLE